A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema
Clinical trial NCT05151744 · COMPLETED
Trial details
- NCT number
- NCT05151744
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-17
- Primary completion
- 2024-04-17
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.